Deviation – Page 161

E&L Failure during EU/UK distribution qualification: GMP investigation and CAPA evidence pack

GMP Investigation and CAPA Evidence Pack for E&L Failure during EU/UK Distribution Qualification Effective investigation of Extractables and Leachables (E&L) failures during EU/UK distribution qualification is critical in pharmaceutical manufacturing.…

API co-crystal / salt form inconsistency after raw material supplier change: root cause analysis (process vs lab) with CAPA effectiveness checks

Analyzing API Co-Crystal/Salt Form Inconsistency After Changes in Raw Material Suppliers In recent times, pharmaceutical manufacturers have encountered significant challenges related to the inconsistency of API co-crystals or salt forms…

Phase Separation in otic suspension filling: GMP documentation for FDA/EMA/MHRA review

Addressing Phase Separation in Otic Suspension Filling: A GMP Investigation Guide Phase separation is a critical issue that can jeopardize the integrity of otic suspension formulations during the filling process.…

Spray Pattern Failure at stability pull: method variability vs true product failure assessment

Analyzing Spray Pattern Failures During Stability Pull: A Comprehensive Investigation Approach In the realm of pharmaceutical manufacturing, particularly concerning aerosol formulations, the integrity of the spray pattern is crucial for…

Canister Corrosion during line setup: packaging integrity and transport risk assessment

Addressing Canister Corrosion during Line Setup: A Comprehensive Investigation Guide Canister corrosion during line setup can pose significant risks to packaging integrity and product safety in pharmaceutical manufacturing. As the…

Pet Failure after supplier change: manufacturing vs lab root cause decision tree

Analyzing Pet Failure After Supplier Change: Manufacturing vs Lab Root Cause Decision Tree In the pharmaceutical industry, changes in suppliers can often lead to unexpected failures in product quality, such…

Valve Malfunction after valve supplier change: FDA/MHRA inspection-ready documentation

Investigating Valve Malfunction Following Supplier Change in Pharmaceutical Manufacturing In the realm of pharmaceutical manufacturing, changes in suppliers for critical components like valves can inadvertently lead to operational challenges, including…

Spray Pattern Failure in aerosol filling: packaging integrity and transport risk assessment

Investigation of Spray Pattern Deficiencies in Aerosol Filling: A Risk-Based Approach The integrity of aerosol filling processes is crucial for ensuring product quality and consistency in the pharmaceutical industry. A…

Leakage Failure during EU/UK distribution qualification: packaging integrity and transport risk assessment

Investigating Leakage Failures in EU/UK Distribution Qualification: A Comprehensive Approach In the competitive landscape of pharmaceutical manufacturing, ensuring product integrity throughout the distribution lifecycle is paramount. A common yet critical…

Fill Volume Variability during inspection readiness: manufacturing vs lab root cause decision tree

Analyzing Fill Volume Variability: A Comprehensive Investigation for Manufacturing and Lab Settings Fill volume variability can pose significant challenges during inspection readiness, impacting both manufacturing processes and laboratory assessments. Whether…

Canister Corrosion in MDI assembly: method variability vs true product failure assessment

Assessing Canister Corrosion in MDI Assembly: Distinguishing Method Variability from True Product Failures Canister corrosion is a critical issue impacting the integrity and efficacy of Metered-Dose Inhalers (MDIs). This problem…

Particle Size Distribution Oos after valve supplier change: GMP investigation and CAPA evidence pack

Investigating OOS in Particle Size Distribution Following a Change in Valve Supplier In the ever-evolving landscape of pharmaceutical manufacturing, maintaining consistent product quality is paramount. An Out of Specification (OOS)…